ARTLVSXXII• 7 Days (Normalized)
ARTL vs XXII (Artelo Biosciences Inc. vs 22nd Century Group Inc.)
Showing Closing Date Range from Sep 23 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ARTL Performance $4.54
-37.89%
Artelo Biosciences Inc.
Normalized Baseline0.00%
XXII Performance $1.33
-43.16%
22nd Century Group Inc.
Normalized Baseline0.00%
Alpha Spread Margin ARTL LEADS
+5.27 pts
ARTL outperforming by 5.27 percentage points
ARTLXXII
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ARTL XXII
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(3 dates)
| Date | ARTL Price | ARTL Gain (%) | XXII Price | XXII Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 25, 2026 | $4.54 | -37.89% | $1.33 | -43.16% | +5.27% |
| Sep 24, 2026 | $5.17 | -29.27% | $1.51 | -35.47% | +6.20% |
| Sep 23, 2026 | $7.31 | +0.00% | $2.34 | +0.00% | +0.00% |